Intellectual property
Overcoming market failure: The challenge of neglected diseases
Jan 2013
Chapter
There is a particular problem in incentivizing medical R&D for diseases that disproportionately affect poor people in developing countries as the market mechanisms, such as intellectual property rights (IPRs), do not work in this case. A key factor is the limited purchasing power of both governments and patients in the countries where such diseases predominate; unlike for other diseases, there is no positive spillover from drug development targete Read More
Geographical indications
Nov 2020
Chapter
This chapter explains the provisions of Section 3 of Part II of the TRIPS Agreement entitled ‘Geographical Indications’. A geographical indication (GI) is defined in the TRIPS Agreement as an indication which identifies a good as originating in the territory of a member, or a regional locality in that territory, where a given quality, reputation or other characteristic of the good is essentially attributable to its geographical origin. Typical examples would be ‘Cogna Read More
Appendices
Oct 2015
Chapter
I would like to thank you very much for inviting me to this Symposium. It is really great to be back in Geneva. I have, indeed, very fond memories of my long stay here and coming back gives me the great pleasure to meet dear, old friends.
Revisiting the TRIPS negotiations: Genesis and structure of this book
Oct 2015
Chapter
The 1986 Punta del Este Declaration inaugurated a set of negotiations on “traderelated aspects of intellectual property rights” as part of the Uruguay Round mandate for multilateral trade negotiations. These negotiations led, ultimately, to the conclusion of the TRIPS Agreement, an integral element of the single undertaking constituting the legal framework for the newly established WTO which came into existence in 1995.
Un monde de possibilités … et de défis
Apr 2019
Chapter
D’après une étude publiée par le Parlement européen en 2017, la chaîne de blocs pourrait « changer nos vies » (Boucher, 2017). Ce que montrent les différentes applications de la chaîne de blocs qui sont mises au point dans des domaines aussi divers que le financement du commerce, la facilitation des échanges, le commerce des services, la propriété intellectuelle et les marchés publics, c’est que la chaîne de blocs peut avoir un impact considéra Read More
Preface
Oct 2015
Chapter
This book was conceived in mid-2014 when members of the Intellectual Property Division (IPD) of the WTO began to reflect on what facets of the Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS) could be highlighted for WTO members and the public at large in 2015, a year marking the 20th anniversary both of the WTO and of the entry into force of the TRIPS Agreement. The IPD, under the leadership of its Director, Antony Taubm Read More
Working together towards TRIPS
Oct 2015
Chapter
The negotiations on IP during the Uruguay Round of multilateral trade negotiations of the GATT (1986–94) were able to build upon a large body of existing law, both international and domestic. The main disciplines and notions of IP protection were already well established at the inception of the negotiations in 1986, with the adoption of the Ministerial Declaration in Punta del Este and its compromise that meant that negotiations would be conducted only Read More
Undisclosed information, unfair competition and anti-competitive practices
Nov 2020
Chapter
This chapter deals with the provisions of the TRIPS Agreement that set out standards for protection of undisclosed information, including test data (Article 39 of Section 7 in Part II of the Agreement) and measures for the control of anti-competitive practices in licences (Article 40 of Part II of the TRIPS Agreement). It also deals with the suppression of unfair competition, a matter which is specifically referred to in Articles 22 (relating to protection of geographi Read More
Industrial designs and layout-designs of integrated circuits
Nov 2020
Chapter
This chapter deals with the provisions of the TRIPS Agreement that set out standards for protection of industrial designs (Articles 25 and 26 in Section 4 of Part II of the Agreement) and protection of layout-designs or topographies of integrated circuits (Articles 35 to 38 in Section 6 of Part II). As for all sections of Part II, these sections have to be read together with the relevant provisions of pre-existing treaties in the area of international IP law, which are in Read More
Introduction
Nov 2018
Chapter
The world is continually changing, driven by technological innovations that affect the way we live and do business. The history of the world economy is intimately linked to technological progress. The invention of the steam engine mechanized production, the discovery of electricity enabled mass production, and the rise of the internet made it possible to coordinate various production stages at a distance, leading to a fragmentation of production that g Read More
Acknowledgements
Nov 2018
Chapter
My sincere thanks go to my colleague Ms Kenza Le Mentec for her precious guidance. Kenza introduced me to the subject and provided invaluable inputs, in particular for the technical sections describing the technology and the section on trade facilitation. This publication would not have been possible without her support.
Negotiating for Switzerland
Oct 2015
Chapter
Learning is a continuing process in one’s life. Some lessons are well archived on our “personal hard disk”, with learning by doing being the most efficient method of saving those lessons. Negotiating the TRIPS Agreement was “unforgettable”, to cite a famous American TV series. Indeed, it is one of the most well-archived and prominent learning experiences of my career. Having been born and grown up in a developing country, namely, Viet Nam (sout Read More
Acknowledgements
Jul 2020
Chapter
This publication is the product of extensive collaboration between the WHO, WIPO and WTO Secretariats, led by the Department of Public Health, Innovation and Intellectual Property in the WHO, the Global Challenges Division in WIPO and the Intellectual Property, Government Procurement and Competition Division in the WTO.
Un mundo de oportunidades ... y de retos
Apr 2019
Chapter
En 2017 el Parlamento Europeo publicó una investigación en la que se afirmaba que las cadenas de bloques podían "cambiarnos la vida" (Boucher, 2017). Lo que demuestran las varias aplicaciones de la cadena de bloques que se están desarrollando en esferas tan diversas como la financiación del comercio, la facilitación del comercio, el comercio de servicios, la propiedad intelectual y la contratación pública es que esta tecnología puede tener repercusi Read More
Enforcement
Nov 2020
Chapter
The purpose of this chapter is to introduce the key features of the provisions of Part III, Sections 1 to 5, of the TRIPS Agreement entitled ‘Enforcement of Intellectual Property Rights’. This Part of the Agreement elaborates in 21 articles the enforcement procedures that members have to make available to permit prompt and effective action against infringements of IPRs covered by the TRIPS Agreement.
Intellectual property, trade and other policy dimensions
Jan 2013
Chapter
This section provides an overview of elements and legal and policy instruments relating to the IP and international trade system which are relevant to medical innovation and access to medical technologies at the international level.
Can Blockchain revolutionize international trade?
Nov 2018
Chapter
The number of headlines claiming that Blockchain can revolutionize various areas of international trade, from trade finance to customs procedures and intellectual property, are legion. The transparent, decentralized and immutable nature of Blockchain has sparked the interest of private actors – and governments – to explore the potential of this technology to enhance the efficiency of trade processes, and a myriad of proofs of concepts and pil Read More
Economics of innovation and access to medical technologies
Jan 2013
Chapter
The past decade has seen more systematic efforts to use the tools of economic analysis to support discussions on health policy, particularly in developing economies. The WHO Commission on Macroeconomics and Health (WHO, 2001a) was a major milestone along this road. The present study does not attempt to advance economic analysis and the theoretical understanding of the economics of technology innovation and access issues. Rather, it recogniz Read More
Agradecimientos
Apr 2019
Chapter
Quiero expresar mi más sincero agradecimiento a mi colega, la Sra. Kenza Le Mentec, por sus valiosas orientaciones. Kenza me dio a conocer el tema e hizo importantes aportaciones, en particular para las secciones técnicas en que se describe la tecnología y para la dedicada a la facilitación del comercio. Esta publicación no hubiera sido posible sin su apoyo.
Introducción
Apr 2019
Chapter
El mundo está en continuo proceso de cambio, impulsado por innovaciones tecnológicas que afectan la forma en que vivimos y hacemos negocios. La historia de la economía mundial está íntimamente ligada al progreso tecnológico. La máquina de vapor facilitó la mecanización de la producción, el descubrimiento de electricidad permitió la producción en masa y la aparición de Internet permitió coordinar a distancia las diversas fases de prod Read More
A dramatic impact on health systems and responses at the global level
Sept 2021
Chapter
The coronavirus disease 2019 (COVID-19) pandemic constitutes an extraordinary global public health crisis. It has created a pressing need for intensified global cooperation. The pandemic has, from its outset, raised issues at the crossroads of public health, trade, intellectual property (IP) policy, and the framework for and management of innovation and access, including issues related to technology transfer.
Réponses sous la forme de réglementations
Jun 2023
Chapter
L’évaluation réglementaire et l’approbation des technologies de la santé sont essentielles dans tout système de santé pour garantir la qualité, la sécurité et l’efficacité des produits. Aucun traitement efficace contre la COVID-19 n’a encore été trouvé. Des essais cliniques sont en cours concernant de nouveaux traitements ainsi que des médicaments affectés à un nouvel usage. Un « usage compassionnel » des médicaments (c’est-à-dire une utilisation clin Read More
Aspectos relacionados con la propiedad intelectual
Jun 2023
Chapter
El régimen mundial de propiedad intelectual ofrece un marco de incentivos que permite fomentar la innovación urgente necesaria para luchar contra la COVID-19. Abarca desde las fases de invención hasta el suministro de un producto o servicio. Las repercusiones de las patentes en el acceso a los medicamentos es un asunto complejo que despierta especial interés. También se analizan otros derechos de propiedad intelectual, como los secr Read More
Intellectual property aspects
Sept 2021
Chapter
The global IP system provides an incentive framework in which urgently needed innovation in relation to COVID-19 can be encouraged. It covers the stages from invention to supply of a product or service. The impact of patents on access is complex and an area of particular focus. Other IP rights, including trade secrets, are also being discussed. IP policy and the administration and enforcement of IP laws aim to balance and accommodate a range of intere Read More
Introducción
Jun 2023
Chapter
La segunda edición de la publicación conjunta de la OMS, la OMPI y la OMC titulada Promover el acceso a las tecnologías y la innovación en medicina: Intersecciones entre la salud pública, la propiedad intelectual y el comercio (el estudio trilateral), publicada en 2020, incluía un suplemento especial en que se presentaban los desafíos planteados por la pandemia de COVID-19 en relación con los marcos de política integrados de salud, comercio y propi Read More
The way forward
Sept 2021
Chapter
The COVID-19 pandemic has placed immense pressure on health systems and trade systems around the world. The urgent search for technologies that may help to control the pandemic has mobilized unprecedented research efforts and investments. It has given rise to new models of working. Rapid and efficient innovation is needed more than ever, and global equitable access to new technologies is of paramount importance. Adequate management of IP i Read More
Introduction
Sept 2021
Chapter
The second edition of the joint WHO, WIPO and WTO publication “Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade” (the Trilateral Study), published in 2020, included a special insert mapping the challenges posed by the COVID-19 pandemic in relation to the integrated health, trade and IP policy framework set out in the study. The Trilateral Study and the special insert were d Read More
Asegurar la transparencia
Jun 2023
Chapter
La transparencia y la disponibilidad de información actualizada sobre las medidas adoptadas por los Gobiernos revisten una importancia crucial, y afectan tanto a los aspectos jurídicos como a los aspectos relacionados con las políticas que se abordan en el estudio trilateral.
Technologies relatives à la COVID-19 : initiatives internationales visant à appuyer la R&D et un accès équitable
Jun 2023
Chapter
Depuis le début de la pandémie de COVID-19, une multitude d’acteurs publics et privés se sont efforcés de collaborer à l’échelle mondiale pour mettre au point des traitements, des vaccins et des diagnostics en vue de garantir un accès équitable à ces technologies. De nombreux efforts de ce type visent à répondre simultanément aux besoins en matière de R&D et d’accès. Les efforts de collaboration comprennent des investissements substantiels da Read More
Preservar la eficacia del comercio internacional
Jun 2023
Chapter
Si bien los países de ingresos bajos y medianos tienen especiales dificultades, derivadas de la escasez mundial de tecnologías sanitarias clave, la gran mayoría de los países son importadores netos de todo tipo de tecnologías sanitarias, incluidas las necesarias para luchar contra la COVID-19.
Preserving effective international trade
Sept 2021
Chapter
While low- and middle-income countries face particular challenges caused by the global scarcity of key health technologies, the vast majority of countries are net importers of all categories of health technologies, including those needed to address COVID-19.
No more items...